Hematopoietic Stem Cell Transplant (HSCT) Clinical Trials
2 recruiting trials for Hematopoietic Stem Cell Transplant (HSCT). Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT04098445
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Hematopoietic stem cell transplant (HSCT) is an effective but toxic therapy and pulmonary morbidity affects as many as 25% of children receiving transplant. Early pulmonary injury...
Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 20009 locations
RECRUITINGPhase 2NCT06665100
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial...
The purpose of this research study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity of lung infections...
Sponsor: Pulmotect, Inc.Enrolling: 10011 locations